Revenue and Contract Acquisition Costs (Tables)

9 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Summary of Revenue from Contracts with Customers

The following table summarizes the Company’s disaggregated revenues:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in millions)	2020		2019		2020		2019
U.S. Omnipod	$	132.3	$	109.4	$	377.7	$	293.6
International Omnipod	79.8		67.8		226.1		187.4
Total Omnipod	212.1		177.2		603.8		481.0
Drug Delivery	21.9		14.9		54.5		47.8
Total	$	234.0	$	192.1	$	658.3	$	528.8

Summary of Deferred Revenue

Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:

(in millions)	September 30, 2020		December 31, 2019
Accrued expenses and other current liabilities	$	4.3	$	3.2
Other liabilities	0.9		1.0
Total deferred revenue	$	5.2	$	4.2

Summary of Contract Acquisition Costs

Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:

(in millions)	September 30, 2020		December 31, 2019
Prepaid expenses and other current assets	$	10.4	$	9.5
Other assets	20.7		19.9
Total capitalized contract acquisition costs, net	$	31.1	$	29.4